{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:55:12Z","timestamp":1763535312604},"reference-count":13,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.3892\/ol.2015.3003","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T13:37:18Z","timestamp":1425303438000},"page":"2205-2207","source":"Crossref","is-referenced-by-count":13,"title":["Primary signet-ring cell carcinoma of the lung treated with crizotinib: A case report"],"prefix":"10.3892","volume":"9","author":[{"given":"YUE-QIN","family":"HAO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUA-PING","family":"TANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HONG-YUN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015]]},"reference":[{"key":"key20180103213729_b1-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0046-8177(89)90229-3","article-title":"Primary mucinous adenocarcinoma of the lung with signet-ring cells: a histochemical comparison with signet-ring cell carcinomas of other sites","volume":"20","author":"Kish","year":"1989","journal-title":"Hum Pathol"},{"key":"key20180103213729_b2-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2559.2008.02987.x","article-title":"Signet-ring cell carcinoma component in primary lung adenocarcinoma: potential prognostic factor","volume":"52","author":"Iwasaki","year":"2008","journal-title":"Histopathology"},{"key":"key20180103213729_b3-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK","volume":"27","author":"Shaw","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180103213729_b4-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1158\/1078-0432.CCR-09-0802","article-title":"Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population","volume":"15","author":"Rodig","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180103213729_b5-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"key20180103213729_b6-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-11-2906","article-title":"Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer","volume":"18","author":"Doebele","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180103213729_b7-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/jco.2009.27.15_suppl.3509","article-title":"Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066","volume":"27","author":"Kwak","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180103213729_b8-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180103213729_b9-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00000478-200407000-00004","article-title":"Primary lung carcinoma with signet-ring cell carcinoma components: clinicopathological analysis of 39 cases","volume":"28","author":"Tsuta","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"key20180103213729_b10-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/JTO.0b013e3181ce3b93","article-title":"Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung","volume":"5","author":"Ou","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key20180103213729_b11-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(12)70375-3","article-title":"Crizotinib in ALK-positive lung cancer","volume":"13","author":"Girard","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20180103213729_b12-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.5858\/arpa.2012-0246-RA","article-title":"Treatment of ALK-positive non-small cell lung cancer","volume":"136","author":"Bang","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"key20180103213729_b13-ol-0-0-3003","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1158\/1078-0432.CCR-12-0392","article-title":"Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer","volume":"18","author":"Tanizaki","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3003\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T11:58:25Z","timestamp":1598788705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015]]},"published-print":{"date-parts":[[2015]]}},"alternative-id":["10.3892\/ol.2015.3003"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3003","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}